By generating a 131I-HER2-NB-conjugated radionuclide, Feng et al. [57] proved that, while both site-specific and random NB-tracer conjugation had comparable tumor targeting abilities, the former resulted in lesser accumulation in normal tissues in breast cancer xenograft mice. Here, ERBB2 is linked to breast carcinoma.